Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay.

Grillberger R, Gruber B, Skalicky S, Schrenk G, Knöbl P, Plaimauer B, Turecek PL, Scheiflinger F, Rottensteiner H.

J Thromb Haemost. 2014 Sep;12(9):1523-32. doi: 10.1111/jth.12653. Epub 2014 Jul 29.

2.

Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.

Grillberger R, Casina VC, Turecek PL, Zheng XL, Rottensteiner H, Scheiflinger F.

Haematologica. 2014 Apr;99(4):e58-60. doi: 10.3324/haematol.2013.100685. Epub 2014 Feb 14. No abstract available.

3.

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.

Benhamou Y, Assié C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Provôt F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Coppo P; Thrombotic Microangiopathies Reference Center.

Haematologica. 2012 Aug;97(8):1181-6. Epub 2012 May 11.

Supplemental Content

Loading ...
Support Center